Please check your internet connection and try again.
# Lorazepam (A Representative Benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. It enhances the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system.
## Primary Indications
* **Anxiety Disorders:** Short-term management of anxiety symptoms.
* **Insomnia:** Short-term treatment of insomnia characterized by difficulty falling or staying asleep.
* **Status Epilepticus:** First-line treatment for status epilepticus.
* **Sedation:** Premedication before surgical or diagnostic procedures; management of agitation.
## Adult Dosing
* **Anxiety:** 1-4 mg orally or IM every 6-8 hours as needed. Maximum daily dose generally 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IM or IV. A second dose of 4 mg can be administered after 10-15 minutes if seizures persist. Maximum initial dose 4 mg.
* **Premedication:** 2-4 mg IM 2 hours before surgery, or 2 mg IV 15-30 minutes before induction.
## Pediatric Dosing
Dosing in children is less well-established and should be individualized based on age, weight, and clinical response.
* **Anxiety:** 0.02-0.1 mg/kg/dose orally or IM every 4-8 hours. Maximum dose typically 4 mg/day.
* **Status Epilepticus:** 0.1 mg/kg/dose IV, maximum 4 mg/dose. Repeat after 10-15 minutes if needed.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require reduced dosage.
* **Renal Impairment:** Use with caution, may require reduced dosage.
* **Elderly:** Initiate at lower doses (e.g., 0.5-1 mg orally twice daily for anxiety) due to increased sensitivity and risk of adverse effects.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, ataxia, confusion, sedation, fatigue.
Less common: Paradoxical reactions (agitation, excitement), amnesia, visual disturbances, hypotension, respiratory depression (especially with IV administration or in combination with other CNS depressants).
## Key Drug Interactions
* **CNS Depressants (alcohol, opioids, antihistamines, antipsychotics, other benzodiazepines):** Additive CNS depression, increasing risk of sedation, respiratory depression, and coma. Use with caution and consider dose reduction.
* **CYP450 Inhibitors/Inducers:** While lorazepam is primarily metabolized by glucuronidation (not CYP450), potential interactions exist.
* **Sodium Oxybate:** Lorazepam is contraindicated with sodium oxybate due to severe respiratory depression risk.
## Monitoring
* Sedation level.
* Respiratory rate and oxygen saturation (especially with IV administration or in combination with other respiratory depressants).
* Cognitive function and signs of paradoxical reactions.
* Signs of dependence and withdrawal symptoms with prolonged use or abrupt discontinuation.
## Clinical Pearls
* Lorazepam has a relatively rapid onset of action, particularly with IV/IM administration.
* Due to its short half-life, it is less suitable for long-term management of chronic insomnia compared to longer-acting agents.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms, including rebound insomnia, anxiety, tremors, and seizures. Tapering is recommended.
* Intravenous administration can cause respiratory depression and hypotension; administer slowly and monitor closely.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making any clinical decisions.*
